Geneos Wealth Management Inc. Agios Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jun 17, 2021	SELL	$44.23 - $57.5 $4,423 - $5,750	-100 Closed	0 $0
Q4 2019 Sep 07, 2021	SELL	$30.08 - $50.59 $7,128 - $11,989	-237 Reduced 70.33%	100 $4,000
Q2 2018 Sep 07, 2021	SELL	$73.22 - $99.55 $1,464 - $1,991	-20 Reduced 5.6%	337 $28,000
Q4 2017 Sep 07, 2021	BUY	$52.12 - $72.33 $11,466 - $15,912	220 Added 160.58%	357 $20,000
Q3 2017 Sep 07, 2021	SELL	$54.89 - $67.12 $16,467 - $20,136	-300 Reduced 68.65%	137 $9,000
Q2 2016 Sep 07, 2021	BUY	N/A	237 Added 118.5%	437 $18,000
Q1 2016 Sep 07, 2021	BUY	N/A	200	200 $8,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.